// App-Quantinova.ai

: Meta-Analysis of Long-Term Risk of Recurrent Venous Thromboembolism after Stopping Anticoagulation in Men and Women with First Unprovoked Venous Thromboembolism

Researchers

Presenter

  • Faizan Khan

Principal Investigators

  • Marc Carrier

  • Clive Kearon

  • Jeffrey I. Weitz

  • Sam Schulman

  • Francis Couturaud

  • Sabine Eichinger

  • Paul Alexander Kyrle

  • Cecilia Becattini

  • Giancarlo Agnelli

  • Timothy Brighton

  • Anthonie WA. Lensing

  • Martin H. Prins

  • Elham Sabri

  • Brian Hutton

  • Laurent Pinede

  • Mary Cushman

  • Gualtiero Palareti

  • George Wells

  • Paolo Prandoni

  • Harry R. Bller

  • Marc A. Rodger

Medical Centers

  • Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada

  • School of Epidemiology and Public Health, Ottawa University, Ottawa, Ontario, Canada

  • Univ of Ottawa, Ottawa, Canada

  • Ottawa Blood Disease Centre, The Ottawa Hospital, Ottawa, Canada

  • The Ottawa Hospital Research Institute, Ottawa, ON, Canada

  • McMaster University, Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada

  • Department of Medicine - Division of Hematology and Thromboembolism, McMaster University, Hamilton, ON, Canada

  • CHU Brest, Brest, France

  • Medical University of Vienna, Vienna, Austria

  • Department of Medicine I, Medical University of Vienna, Austria

  • University of Perugia, Perugia, ITA

  • University of Perugia, Terni, Perugia, Italy

  • Prince of Wales Hospital, Sydney, Australia

  • Bayer Pharma AG, Berlin, Germany

  • Department of Epidemiology and Technology Assessment, University of Maastricht, Maastricht, NLD

  • The Ottawa Hospital Research Institute, Ottawa, ON, Canada

  • Infirmerie Protestante, Lyon, France

  • Larner College of Medicine at the University of Vermont

  • Department of CardioThoracic and Vascular Sciences, University of Padova, Padova, Italy

  • Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

  • Division of Hematology, Department of Medicine, Ottawa Hospital Research Institute, Ottawa, Canada

  • Division of Hematology, Department of Medicine, The Ottawa Hospital, Ottawa Blood Disease Centre, Ottawa, Canada

Locations

  • Canada

  • France

  • Austria

  • Italy

  • Australia

  • Germany

  • United States

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Observational

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved